WO170
WO170 is a KCNT1 inhibitor that can be used in studies related to diseases associated with KCNT1 dysfunction, such as epilepsy.
For research use only. We do not sell to patients.
- CAS No.: 3109711-34-1
- Formula: C25H21N5O
- Molecular Weight:407.47
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 3109711-34-1
-
Molecular Weight 407.47
-
Formula C25H21N5O
-
SMILES
N#CC1=CC2=C(N[C@H]3CCCC4=C3N=C(O4)C5=CC(C6CC6)=NC=C5)N=CC=C2C=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- WO170
- 3109711-34-1
- WO 170
- WO-170
- Drug Derivative
- refractory epilepsy
- post-traumatic epilepsy
- focal epilepsy
- infantile epilepsy with migrating focal seizures
- KCNT1
- generalized epilepsy
- sleep-related hypermotor epilepsy
- autosomal dominant nocturnal frontal lobe epilepsy
- epilepsy
- epileptic encephalopathy
- Inhibitor
- inhibitor
- inhibit